Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing...
-
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
-
Etienna Bio, Inc., announces the formation of its Scientific Advisory Board with the appointment of two internationally recognized leaders in cell biology
-
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
-
Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies" directory has been added to ResearchAndMarkets.com's offering.The International Directory of...
-
Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "European Directory of Biotechnology Companies" directory has been added to ResearchAndMarkets.com's offering.The European Directory of Biotechnology...
-
Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "USA Directory of Biotechnology Companies" directory has been added to ResearchAndMarkets.com's offering.The new USA Directory of Biotechnology...
-
Delray Beach, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets, the global agriculture biotechnology market is set to surge from USD 92.19 billion...
-
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
-
Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "Global Biotech Handbook" directory has been added to ResearchAndMarkets.com's offering. The fully revised and expanded Global Biotech Handbook...